4//SEC Filing
SINGLETON J MATTHEW 4
Accession 0000950170-24-099980
CIK 0001607678other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 7:23 PM ET
Size
8.7 KB
Accession
0000950170-24-099980
Insider Transaction Report
Form 4
SINGLETON J MATTHEW
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-08-21−5,700→ 10,300 totalExercise: $1.19From: 2018-01-03Exp: 2027-01-03→ Common Stock (5,700 underlying) - Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-08-21$1.19/sh+5,700$6,783→ 15,200 total - Sale
Common Stock, par value $0.00001 per share
2024-08-21$69.72/sh−5,700$397,430→ 9,500 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 16, 2024 by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $69.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001243514
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 7:23 PM ET
- Size
- 8.7 KB